Search
forResearch 10 of 1000+
- Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Antibody-drug conjugate induced hair loss responds to minoxidil: A case report
- Antibody Drug Conjugates
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Targeting integrin pathways: mechanisms and advances in therapy
- Hair repigmentation associated with the use of brentuximab
- Meet Our Editor
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
Community 2 of 3
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
- Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!